Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)

NCT03783377 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertriglyceridemia
Familial Chylomicronemia

Interventions

DRUG: ARO-APOC3
DRUG: sterile normal saline (0.9% NaCl)

Sponsor

Arrowhead Pharmaceuticals